On May 29, 2026, Eton Pharmaceuticals Inc (ETON) shares fell 4.3% today, bringing the current price

IMPAVIDO® is the first and only FDA-approved oral therapy for visceral, cutaneous, and mucosal leish

DEER PARK, Ill., May 19, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETO

Eton Pharmaceuticals, Inc. (ETON) Q1 2026 Earnings Call Transcript

Eton Pharmaceuticals NASDAQ: ETON raised its 2026 revenue outlook after reporting record first-quart

Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.05 per share, missing the Z

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.14 per share which beat the ana

Q1 2026 product sales of $24.3 million, representing 73% growth over Q1 2025 Raising full year reven

DEER PARK, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the “Company

DEER PARK, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”

Eton Pharmaceuticals (ETON) witnessed a jump in share price last session on above-average trading vo

HEMANGEOL is now available exclusively through Anovo Specialty Pharmacy to streamline access and the

Eton Pharmaceuticals, Inc ("Eton" or "the Company") (NASDAQ:ETON), an innovative pha

DEER PARK, Ill., April 27, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Compan

On April 16, 2026, Eton Pharmaceuticals Inc (ETON) shares fell 9.4% today, bringing the current pric

Experienced pharmaceutical executive Judith M. Matthews to assume CFO role on June 1st Experienced p

Eton Pharmaceuticals (ETON) saw its shares surge in the last session with trading volume being highe

Eton Pharmaceuticals (ETON) made it through our "Recent Price Strength" screen and could be a great

B. Riley Securities analyst Madison El-Saadi maintains Eton Pharmaceuticals (NASDAQ:ETON) with a

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETO

Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy

The mean of analysts' price targets for Eton Pharmaceuticals (ETON) points to a 49.3% upside in the

Eton Pharmaceuticals, Inc. (ETON) Q4 2025 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.05 per share, missing the Z

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.19 per share which beat the ana

DEER PARK, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Compan

DEER PARK, Ill., March 03, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Compan

Craig-Hallum analyst Chase Knickerbocker maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETO

"As the only treatment for infantile hemangiomas that require systemic therapy, HEMANGEOL is a c

DESMODA is the first and only FDA-approved desmopressin oral solutionCommercial launch expected on M

Eton Pharmaceuticals, Inc ("Eton" or "the Company") (NASDAQ:ETON), an innovative pha

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly earnings of $0.04 per share which missed the a

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.10) per share which missed the a

ET-600 is a proprietary formulation of desmopressin oral solution developed for the treatment of cen

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for it

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 8